Bryan Bennett

Bristol-Myers Squibb (United Kingdom) — United Kingdom

Materials Science · Physical Sciences

32h-index3.2kcitations224works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Luminescence Properties of Advanced Materials(51), Radiation Detection and Scintillator Technologies(32), Health Systems, Economic Evaluations, Quality of Life(22), Crystallization and Solubility Studies(20), X-ray Diffraction in Crystallography(20)

Publications224 total

Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX study
Journal for ImmunoTherapy of Cancer·2025Open Access
Predicting Danish EQ-5D-5L Utilities Based on United Kingdom EQ-5D-3L Utilities for Use in Health Economic Models
PharmacoEconomics - Open·2025· 1 citedOpen Access
Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years
Frontiers in Pharmacology·2024· 21 citedOpen Access
CO159 Challenges on Outcomes Selection Along Early to Late Phase Clinical Trials of Drug Development: Survey to Experts in Neurosciences Drug Development
Value in Health·2024Open Access
Transradial-based thoracic branch endograft repair for thoracic aortic aneurysms experience at a suburban community hospital
Journal of Vascular Surgery Cases and Innovative Techniques·2024Open Access
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
Health and Quality of Life Outcomes·2024· 19 citedOpen Access
A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment
Health and Quality of Life Outcomes·2024· 9 citedOpen Access
Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma
Patient·2024· 1 cited
Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancer
Frontiers in Pharmacology·2024· 3 citedOpen Access
A Methodological Study to Compare Alternative Modes of Administration to Value EQ-5D Using Preference-Elicitation Techniques
Value in Health·2024· 5 citedOpen Access
Correction to: A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature
Patient·2024Open Access
Lanthanide based polymers and ionic liquids
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2024Open Access
Synthesis and optical properties of CsC1-doped gallium-sodium-sulfide glasses
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2024Open Access
A Review of Meaningful Change Thresholds for EORTC QLQ-C30 and FACT-G Within Oncology
Value in Health·2024· 13 citedOpen Access
A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature
Patient·2023· 15 citedOpen Access
IO-Synthesise RCC: relationship between baseline health-related quality of life and clinical outcomes of nivolumab in patients with previously treated metastatic renal cell carcinoma using pooled real-world data from France and Germany
European Urology Open Science·2023Open Access
616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study
Regular and Young Investigator Award Abstracts·2023Open Access
Assessing the Content Validity of Preference-Based Measures in Cancer
Value in Health·2023· 15 citedOpen Access
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Cancers·2023· 6 citedOpen Access
PCR119 The Impacts of Age and Gender on Mapped EQ-5D-5L Utilities and Quality-Adjusted Life Years (QALYS) in Cancer Clinical Trials
Value in Health·2023· 1 cited
page 1 of 12Next →

Frequent Co-authors

D. W. Cooke(23), R. E. Muenchausen(19), Luiz G. Jacobsohn(11), Edward A. McKigney(6), K. J. McClellan(6), J. M. Roper(5), Mark Whittaker(5), James F. Smith(5), Michael W. Blair(5), Stephanie C Tornga(4), A. M. Portis(4), Fiona Taylor(3), Michael DeRosa(3), J.-K. Lee(3), M. Nastasi(3), Kurt E. Sickafus(3), James A. Valdez(3), E.H. Farnum(3), J. L. Smith(3), Tanja Kastien-Hilka(3)